Equitable access to polycythemia vera treatments: addressing reimbursement disparities in Europe Massimo BrecciaTiziano Barbui Editorial 24 July 2024 Pages: 3285 - 3286
Myeloproliferative neoplasms: young patients, current data and future considerations Marta SobasJean-Christophe IanottoClaire Harrison Editorial 07 August 2024 Pages: 3287 - 3291
The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis Zerong WangXuelian JinXinchuan Chen Review Article Open access 18 March 2024 Pages: 3293 - 3301
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy Wanying LiuXiaojian ZhuYi Xiao Review Article Open access 20 May 2024 Pages: 3303 - 3313
Advances in biology, diagnosis and treatment of DLBCL Yuanfei ShiYi XuWanzhuo Xie Review Article Open access 17 July 2024 Pages: 3315 - 3334
Speckle tracking echocardiography and β-thalassemia major. A systematic review Dimitrios PatsourakosConstantina AggeliKonstantinos Tsioufis Review Article Open access 01 August 2023 Pages: 3335 - 3356
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials Songphol TungjitviboonkunNaharuthai BumrungratanayosSmuch Siramongkholkarn Review Open access 10 June 2024 Pages: 3357 - 3368
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update Tadeusz RobakAnna PułaEwa Robak Review Open access 25 July 2024 Pages: 3369 - 3383
The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia Mengting YangYanhui TangYou Yang Review Article 27 December 2023 Pages: 3385 - 3398
Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports M Bakri HammamiAsma QasimAbhishek Kumar Review Article 19 July 2023 Pages: 3399 - 3411
The roles of ubiquitination in AML Zhifeng WeiLong SuSujun Gao Review Article 21 August 2023 Pages: 3413 - 3428
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia Jeffrey H. LiptonTim H. BrümmendorfJorge E. Cortes Review Open access 18 July 2024 Pages: 3429 - 3442
Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study Mirza Faris Ali BaigKalyan Chaliki Research 03 August 2024 Pages: 3443 - 3451
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study Zhengrui XiaoZhiqiang HeIrina Murakhovskaya Research Open access 12 June 2024 Pages: 3453 - 3461
The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease Dongfei YinJingshi WangZhao Wang Research 21 May 2024 Pages: 3463 - 3472
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes Eman Mahmoud EzzatSalwa BakrNourhan Mohamed Nasr Research Open access 19 July 2024 Pages: 3473 - 3482
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence Xiaoli LiXiaohui ShangguanLimin Liu Research 01 August 2024 Pages: 3483 - 3491
Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study Fatma Soliman Elsayed EbeidNihal Hussien AlySara Mostafa Makkeyah Research Open access 19 July 2024 Pages: 3493 - 3506
The role of clonal progression leading to the development of therapy-related myeloid neoplasms Luca GuarneraMaria Rosaria PascaleEmiliano Fabiani Research Open access 20 July 2024 Pages: 3507 - 3517
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters Dina N. LaimonDoaa H. SakrYasmine Shaaban Research Open access 10 July 2024 Pages: 3519 - 3533
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis Keiki NagaharuEiko OhyaYuka Sugimoto Research 22 July 2024 Pages: 3535 - 3541
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database John YanM. Bakri HammamiSwati Goel Research Open access 24 July 2024 Pages: 3543 - 3551
Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR Yiyi LuLin LinXuefei Ma Research Open access 24 July 2024 Pages: 3553 - 3562
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study Wenxi HuaJiaqian QiYue Han Research 16 July 2024 Pages: 3563 - 3572
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis Ghaith Abu-ZeinahAlbert QinRuben Mesa Research Open access 15 August 2024 Pages: 3573 - 3583
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study Alon RozentalErez HalperinAdi Shacham-Abulafia Research Open access 11 June 2024 Pages: 3585 - 3594
Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia Yu ZhaoYun HuangXuejie Jiang Research 18 July 2024 Pages: 3595 - 3604
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study Leyu WangLiwei FangBing Han Research 22 June 2024 Pages: 3605 - 3613
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea Seok Jin KimSeug Yun YoonJunice Ng Research 06 August 2024 Pages: 3615 - 3625
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells Yanyan ZhangFen HeJiliang Xia Research 22 April 2024 Pages: 3627 - 3637
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia Jiawang OuShiyu DengHongsheng Zhou Research 07 March 2024 Pages: 3639 - 3648
Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients Shijia ChengZheng YanYanyan Liu Research 30 July 2024 Pages: 3649 - 3656
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia Xiao-Tong HuangChan-Juan WangZhi-Gang Li Research 18 March 2024 Pages: 3657 - 3665
Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia Jia ChenMing-nan JiaXin-xin Cao Research 06 March 2024 Pages: 3667 - 3675
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study Bin ChuYu-tong WangLi Bao Research Open access 03 July 2024 Pages: 3677 - 3690
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study Jingjing DengXiaoqi QinWenming Chen Research 29 July 2024 Pages: 3691 - 3699
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study Salvatore LeottaUros MarkovicGiuseppe Milone Research 13 April 2024 Pages: 3701 - 3712
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma Sara PellegrinoDavide OrigliaRosa Fonti Research Open access 24 July 2024 Pages: 3713 - 3721
CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation Xie JuanZeying FanXiangyu Zhao Research 11 June 2024 Pages: 3723 - 3735
Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies Emily R. CoxCorinne SummersMonica S. Thakar Research 14 July 2024 Pages: 3737 - 3743
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome–positive acute lymphoblastic leukaemia Lijuan HuZongru LiQian Jiang Research 05 March 2024 Pages: 3745 - 3754
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis Alexander DenkCornelia MittermaierDaniel Wolff Research Open access 25 June 2024 Pages: 3755 - 3764
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies Yanlu DuYing ZhangXianmin Song Research 10 July 2024 Pages: 3765 - 3774
Allogeneic stem cell transplant in primary hemophagocytic lymphohistiocytosis – a single-center experience Fayyaz HussainMussawair HussainRaheel Iftikhar Research 24 July 2024 Pages: 3775 - 3782
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report Valentina Maria ManieriMassimo OffidaniSonia Morè Case Report 14 June 2024 Pages: 3783 - 3786
TEMPI syndrome: difficult to diagnose, “easy” to treat? Despina FotiouEirini SoliaEfstathios Kastritis Case Report 30 July 2024 Pages: 3787 - 3793
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases Qingwei WangYixin HuShaoyan Hu Case Report Open access 28 May 2024 Pages: 3795 - 3800
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate Fei Chen Case Report 12 July 2024 Pages: 3801 - 3804
De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence Ekta JajodiaHemant MenghaniAnkit Jitani Case Report 11 July 2024 Pages: 3805 - 3810
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting Taku KikuchiNobuhiro TsukadaTadao Ishida Correspondence 06 June 2024 Pages: 3811 - 3813
